? Candidate: Dr. Myles Wolf received the M.D. degree in 1996 from SUNY-Brooklyn. He completed internal medicine and nephrology training at MGH. In 2002, he received the Master of Medical Sciences degree in clinical physiological investigation from Harvard Medical School through its NIH K30-supported Scholars in Clinical Science Program. Mentor: David Nathan, M.D., is a world-renowned clinical investigator who has trained numerous investigators in the areas of diabetes and insulin resistance, a field in which he has published extensively. As Director of the MGH GCRC and as a founding member of the Scholars in Clinical Science Program, Dr. Nathan will ensure the success of Dr. Wolf's research training, project and overall career development. Research: cardiovascular disease (CVD) is the leading cause of mortality among women in the U.S. Reducing its burden requires further understanding of its early mechanisms. Women with hypertensive disorders of pregnancy (HDP), including preeclampsia and gestational hypertension, return to their normotensive baseline soon after delivery, yet they are at increased risk for CVD in later years. Therefore, these women represent in-vivo human models of the pre-CVD state in whom its early mechanisms may be studied. In their first study, they will test the hypothesis that otherwise asymptomatic women with prior HDP display evidence of increased CVD risk relative to those with normal pregnancy as early as one year postpartum. In addition to examining traditional CVD risk factors, they will focus on insulin resistance, inflammation and microalbuminuria, factors that are associated with HDP but have been understudied in the postpartum period. In a second physiological study, they will examine vascular reactivity using brachial artery ultrasound, and insulin sensitivity using intravenous glucose tolerance tests. The hypotheses to be tested are that women with HDP display evidence of endothelial dysfunction during the early postpartum period and that this alteration is related to insulin resistance. All subjects will be identified from the MGH Obstetric Maternal Study, the largest pregnancy cohort in Massachusetts, and the source of several important studies during pregnancy. The proposed study is sufficiently powered (>90%), IRB-approved and pilot data support its feasibility. They believe the results will provide critical insight into mechanisms of CVD in women and potentially suggest means to alter their CVD risk. ? ?
| Rienstra, Michiel; Cheng, Susan; Larson, Martin G et al. (2011) Vitamin D status is not related to development of atrial fibrillation in the community. Am Heart J 162:538-41 |
| Isakova, Tamara; Gutierrez, Orlando M; Chang, Yuchiao et al. (2009) Phosphorus binders and survival on hemodialysis. J Am Soc Nephrol 20:388-96 |
| Gutiérrez, Orlando M; Januzzi, James L; Isakova, Tamara et al. (2009) Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation 119:2545-52 |
| Wang, Thomas J; Pencina, Michael J; Booth, Sarah L et al. (2008) Vitamin D deficiency and risk of cardiovascular disease. Circulation 117:503-11 |
| Wolf, Myles; Betancourt, Joseph; Chang, Yuchiao et al. (2008) Impact of activated vitamin D and race on survival among hemodialysis patients. J Am Soc Nephrol 19:1379-88 |
| Isakova, Tamara; Gutierrez, Orlando; Shah, Anand et al. (2008) Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD. J Am Soc Nephrol 19:615-23 |
| Gutierrez, O M; Isakova, T; Andress, D L et al. (2008) Prevalence and severity of disordered mineral metabolism in Blacks with chronic kidney disease. Kidney Int 73:956-62 |
| Gutierrez, Orlando M; Mannstadt, Michael; Isakova, Tamara et al. (2008) Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 359:584-92 |
| Chafetz, Ilana; Kuhnreich, Ido; Sammar, Marei et al. (2007) First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction. Am J Obstet Gynecol 197:35.e1-7 |
| Hubel, Carl A; Wallukat, Gerd; Wolf, Myles et al. (2007) Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsia. Hypertension 49:612-7 |
Showing the most recent 10 out of 16 publications
